OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4939-4939
Open Access | Times Cited: 12
Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4939-4939
Open Access | Times Cited: 12
Showing 12 citing articles:
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Life (2021) Vol. 11, Iss. 2, pp. 143-143
Open Access | Times Cited: 45
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Life (2021) Vol. 11, Iss. 2, pp. 143-143
Open Access | Times Cited: 45
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13320-13320
Open Access | Times Cited: 36
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13320-13320
Open Access | Times Cited: 36
Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 7
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 7
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
Rajiv Heda, Masahiko Yazawa, Michelle Shi, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 17, pp. 1864-1882
Open Access | Times Cited: 30
Rajiv Heda, Masahiko Yazawa, Michelle Shi, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 17, pp. 1864-1882
Open Access | Times Cited: 30
Maslinic acid activates renal AMPK/SIRT1 signaling pathway and protects against diabetic nephropathy in mice
Huijuan Gao, Hong Wu
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Huijuan Gao, Hong Wu
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks
Amanda Cheung, Aijaz Ahmed
Clinical and Experimental Gastroenterology (2021) Vol. Volume 14, pp. 457-465
Open Access | Times Cited: 21
Amanda Cheung, Aijaz Ahmed
Clinical and Experimental Gastroenterology (2021) Vol. Volume 14, pp. 457-465
Open Access | Times Cited: 21
Identification of crosstalk genes relating to ECM ‐receptor interaction genes in MASH and DN using bioinformatics and machine learning
Chao Chen, Yuxi He, Ying Ni, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 1
Chao Chen, Yuxi He, Ying Ni, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 1
Salidroside attenuates cardiac dysfunction in a rat model of diabetes
Weiwei Hao, Na Li, Mi Caifeng, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 3
Closed Access | Times Cited: 10
Weiwei Hao, Na Li, Mi Caifeng, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 3
Closed Access | Times Cited: 10
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice
Moritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 966-979
Open Access | Times Cited: 9
Moritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 966-979
Open Access | Times Cited: 9
Unlocking new approaches to Urolithiasis management via Nutraceutical
Ravindra Pal Singh, Anurag Mishra, S. Chandel, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 9, pp. 1124-1131
Closed Access | Times Cited: 3
Ravindra Pal Singh, Anurag Mishra, S. Chandel, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 9, pp. 1124-1131
Closed Access | Times Cited: 3
FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
(2020)
Open Access | Times Cited: 1
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
(2020)
Open Access | Times Cited: 1
Pharmacological effect of sodium-glucose cotransporter 2 inhibitors in reducing the incidence of nephrolithiasis
Arash Najafian, Sadaf Esteki
Journal of Parathyroid Disease (2023) Vol. 11, pp. e11220-e11220
Open Access
Arash Najafian, Sadaf Esteki
Journal of Parathyroid Disease (2023) Vol. 11, pp. e11220-e11220
Open Access
